Cambridge Investment Research Advisors’s BNY Mellon Concentrated Growth ETF BKCG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$224K Buy
6,016
+20
+0.3% +$741 ﹤0.01% 3723
2026
Q1
$204K Sell
5,996
-581
-9% -$20.9K ﹤0.01% 3667
2025
Q4
$240K Buy
6,577
+2
+0% +$72 ﹤0.01% 3414
2025
Q3
$235K Sell
6,575
-3,105
-32% -$108K ﹤0.01% 3346
2025
Q2
$335K Hold
9,680
﹤0.01% 2888
2025
Q1
$299K Buy
+9,680
New +$299K ﹤0.01% 2870

Other funds holding BKCG

Cambridge Investment Research Advisors's BKCG Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its BNY Mellon Concentrated Growth ETF (BKCG) stake by 0.33% in Q2 2026, buying an estimated $741 and bringing the position to 6,016 shares worth $224K. The position accounts for ﹤0.01% of the portfolio, ranked #3723.

Cambridge Investment Research Advisors first reported a position in BKCG in Q1 2025 and has held it in 6 quarters since. The position peaked at $335K in Q2 2025. 26 funds tracked by Wall St. Rank hold BKCG as of Q2 2026.

  • Cambridge Investment Research Advisors held 6,016 shares of BNY Mellon Concentrated Growth ETF worth $224K as of Q2 2026.
  • Cambridge Investment Research Advisors bought 20 BNY Mellon Concentrated Growth ETF shares in Q2 2026, an estimated $741.
  • BNY Mellon Concentrated Growth ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3723 holding.
  • Cambridge Investment Research Advisors first reported a position in BNY Mellon Concentrated Growth ETF in Q1 2025 and has held it in 6 quarters since.
  • Cambridge Investment Research Advisors's BNY Mellon Concentrated Growth ETF position peaked at $335K in Q2 2025.
  • 26 funds tracked by Wall St. Rank held BNY Mellon Concentrated Growth ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.